Conservative Disease Management as a Viable Choice for Elderly Patients with Low-Risk Prostate Cancer

Conservative Disease Management as a Viable Choice for Elderly Patients with Low-Risk Prostate Cancer
shutterstock_98521079A new study led by researchers at the Rutgers Cancer Institute of New Jersey was recently published in the journal European Urology revealing that elderly patients with low-risk prostate cancer can benefit in terms of survival from conservative management of the disease. The study is entitled “Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.” Prostate cancer is the second most common cancer in men, with almost one million new cases diagnosed every year worldwide. It was previously shown that men who were diagnosed with prostate cancer in the early 90s had a higher 10-year survival rate in comparison with men whose cancers were diagnosed in prior decades. This study has now been extended to a follow-up period of 15 years, and evaluated survival rates among older men diagnosed with localized prostate cancer that have been submitted to conservative management. The team conducted a population-based study with 31,137 Medicare patients aged 65 or older who had been diagnosed with early-stage localized prostate cancer between 1992 and 2009, and who had only received conservative mana
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *